Abstract
This review describes the application of a natural defense mechanism to develop effective agents for The post-transcriptional control of gene expression. 2-5A is a unique 2,5-phosphodiester bond linked oligoadenylate, (pp)p5A2(p5A)n , that is elaborated in virus-infected interferon-treated cells. The 2-5A System is an RNA degradation pathway that is an important mechanistic component of interferons action against certain viruses. It may also play a role in the anticellular effects of interferon and in general RNA decay. A major player in the 2-5A-system is the latent and constitutive 2-5A-dependent ribonuclease (RNase L) which upon activation by 2-5A, degrades RNA. This RNase L enzyme can be recruited for antisense therapeutics by linking it to an appropriate oligonucleotide targeted to a chosen RNA. Syntheses of 2-5A, its analogues, 2-5A-antisense, and its modifications are detailed herein. Applications of 2-5A-antisense to particular targets such as HIV, PKR, chronic myelogenous leukemia, telomerase, and respiratory syncytical Virus is described.
Keywords: Oligoadenylate-Based Antisense, Ribonucleases, Apoptosis, 2-5A-ANTI-SENSE(2-5A-AS), Syncytial Virus, Condensation, Coupling agents
Current Medicinal Chemistry
Title: Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy
Volume: 8 Issue: 10
Author(s): Steven A. Adah, Suzanne F. Bayly, Hagen Cramer, Robert H. Silverman and Paul F. Torrence
Affiliation:
Keywords: Oligoadenylate-Based Antisense, Ribonucleases, Apoptosis, 2-5A-ANTI-SENSE(2-5A-AS), Syncytial Virus, Condensation, Coupling agents
Abstract: This review describes the application of a natural defense mechanism to develop effective agents for The post-transcriptional control of gene expression. 2-5A is a unique 2,5-phosphodiester bond linked oligoadenylate, (pp)p5A2(p5A)n , that is elaborated in virus-infected interferon-treated cells. The 2-5A System is an RNA degradation pathway that is an important mechanistic component of interferons action against certain viruses. It may also play a role in the anticellular effects of interferon and in general RNA decay. A major player in the 2-5A-system is the latent and constitutive 2-5A-dependent ribonuclease (RNase L) which upon activation by 2-5A, degrades RNA. This RNase L enzyme can be recruited for antisense therapeutics by linking it to an appropriate oligonucleotide targeted to a chosen RNA. Syntheses of 2-5A, its analogues, 2-5A-antisense, and its modifications are detailed herein. Applications of 2-5A-antisense to particular targets such as HIV, PKR, chronic myelogenous leukemia, telomerase, and respiratory syncytical Virus is described.
Export Options
About this article
Cite this article as:
Adah A. Steven, Bayly F. Suzanne, Cramer Hagen, Silverman H. Robert and Torrence F. Paul, Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy, Current Medicinal Chemistry 2001; 8(10) . https://dx.doi.org/10.2174/0929867013372445
DOI https://dx.doi.org/10.2174/0929867013372445 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Structure-Function Relationships and Clinical Applications of L-Asparaginases
Current Medicinal Chemistry Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
Current Medicinal Chemistry Regulation of TGF-β Signaling by SMADs and its Roles in Tissue Fibrosis
Current Signal Transduction Therapy Tricyclic Structures in Medicinal Chemistry: An Overview of their Recent Uses in Non-CNS Pathologies
Mini-Reviews in Medicinal Chemistry BaltPLA2: A New Phospholipase A2 from Bothrops Alternatus Snake Venom with Antiplatelet Aggregation Activity
Protein & Peptide Letters Alzheimer’s Disease: Physical Activities as an Effective Intervention Tool - A Mini-Review
Current Alzheimer Research Glutamatergic Animal Models of Schizophrenia
Current Pharmaceutical Design Thymidine Phosphorylase: A Two-Face Janus in Anticancer Chemotherapy
Current Cancer Drug Targets Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
Current Neuropharmacology The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review
Protein & Peptide Letters Nanodiagnostic Attainments and Clinical Perspectives on C-Reactive Protein: Cardiovascular Disease Risks Assessment
Current Medicinal Chemistry Anti-atherosclerotic Effects of Spice-Derived Phytochemicals
Current Medicinal Chemistry The Need to Consider Context in the Evaluation of Anti-infectious and Immunomodulatory Effects of Vitamin A and its Derivatives
Current Drug Targets CXCL3 is a Potential Target for Breast Cancer Metastasis
Current Cancer Drug Targets Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
Current Medicinal Chemistry Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets Development of Montelukast Sodium Loaded Niosomal Carriers by Film Hydration Technique
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Dysfunction of Glia-Neuron Communication in Pathophysiology of Schizophrenia
Current Psychiatry Reviews Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Current Drug Targets Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy
Current Cancer Drug Targets